Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Pfizer CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the COVID-19 ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid Services, discussed the impending changes to the ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

Photo: Alamy The Trump administration plans to invest $200 billion into Medicaid to preserve the program and reduce rising ...

Obesity drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) traded higher in the premarket on Friday after The Washington ...

The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...